Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine.
Document Type
Article
Publication Date
12-2021
Publication Title
Cutis
Abstract
Pityriasis rosea is a common, self-limited, papulosquamous eruption, classically presenting along the Langer lines of the skin. We report a clinically typical case of pityriasis rosea that developed following COVID-19 vaccination. As the novel COVID-19 vaccine becomes more widely available during the ongoing COVID-19 pandemic, it is imperative for both patients and clinicians to be aware of its association with the onset of this benign cutaneous eruption.
Volume
108
Issue
6
First Page
317
Last Page
318
Recommended Citation
Valk B, Bender B. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine. Cutis. 2021 Dec;108(6):317-318. doi: 10.12788/cutis.0411. PMID: 35167784.
DOI
10.12788/cutis.0411
ISSN
2326-6929
PubMed ID
35167784
COinS